Tue. Nov 10th, 2026

Endocannabinoid Profile: A Crash Course in Anandamide, Source: http://hqdesktop.net/wallpapers/l/1366x768/47/drugs_marijuana_plants_hemp_1366x768_46454.jpg

Formula: C22H37 NO2

Molecular Mass: 347.53468 g/mol

Decarboxylation Point: ????

Boiling Point: ????

LD50 (Lethal Dose): Currently Unknown for humans, 100mg/kg for mice  (Compare to Nicotine: for rats – 50 mg/kg,  for humans – 0.5-1 mg/kg)

First isolated in 1992, Anandamide is a neurotransmitter and endocannabinoid, meaning a cannabinoid produced within the body. Anandamide, also known as N-Arachidonoylethanolamine or AEA, is  an endogenous cannabinoid that acts as a “key” molecule fitting into the “locks” of the CB1 and CB2 receptors around the body. It’s name is taken from the Sanskrit word ananda, which means bliss, and the word amide, which refers to a type of acid found within the body. Anandamide is thus the bliss amide, though it is more widely called the bliss compound (not to be confused with the spirit molecule, DMT). Very appropriate to the Sanskrit origins of its name, anandamide has been shown to be boosted by doing yoga, which may explain why those yogis are so calm and blissful all the time. Similarly, an anandamide deficiency has been shown to increase anxiety and stress.
Anandamide can be thought of as the body’s version of THC, because it has many of the same therapeutic effects and if it weren’t for the presence of anandamide in the body we wouldn’t have the CB1 and CB2 receptors that all cannabinoids interact with. Anandamide doesn’t exist solely in the human body. Outside of the body this endocannabinoid can be found in chocolate. So next time you’re enjoying a chocolate bar, allow that anandamide to jog your memory, and enjoy those sweet cannabinoids.

Therapeutic Uses

Analgesic – Relieves pain.

Angiogenic – Causes new blood vessels to form from pre-existing blood vessels.

Anti-inflammatory – Reduces inflammation systemically.

Anti-Proliferative – Inhibits cancer cell growth.

Anxiolytic – Relieves anxiety.

Euphoriant – Produces feelings of euphoria, promotes happiness and relaxation.

Neurogenic – Promotes the growth of new brain cells. Specifically within the Hippocampus, an area of the brain responsible for memory and spatial awareness (just like CBD).

Currently Being Studied For

Angiogenesis: Anandamide is unique among cannabinoids for its ability to cause blood cells to split and form new blood cells. This process is known as angiogenesis and its proper functioning is crucial to fighting off the spread of cancer due to the necessity of oxygen, nutrients, and bodily waste removal that come with it.

Anxiety: Anandamide, like THC, has been shown to reduce anxiety. This 2009 study, while done on mice, still sheds plenty of light on the mechanisms that AEA uses to reduce mental stress and anxiety in those experiencing it.

Chris Conrad’s latest book is a great introduction to cannabis, how it affects you and how the industry is taking shape.

Cancer: As early as 1998, Anandamide had been identified as an anti-proliferative compound. This means that, like most cannabinoids, Anandamide helps slow the growth and spread of cancerous cells. Specifically the 1998 study looked at its role in inhibiting the proliferation of breast cancer cells. A more recent study from 2007 showed that AEA not only suppressed the growth of tumors it also spurred the formation of new blood cells. If that wasn’t enough Anandamide also induces COX-2-dependant cell death, a type of apoptosis that helps control the growth of cancerous cells. Specifically, AEA was found to do this in apoptosis resistant colon-cancer cells.

Memory Consolidation: Anandamide has been shown to , a process where things in the short term memory get transferred into the long term memory. This gives Anandamide a very unique and important role in allowing people to function normally and to build on their prior knowledge, rather than having to relearn the same things constantly. You can think of memory consolidation as a fancy way to say learning. This same study emphasized the anti-anxiety effects of AEA.

Check out other posts in the Cannabinoid and Endocannabinoid Profile series.

By Mitchell Colbert

Mitchell Colbert is a lobbyist, freelance journalist, and formerly an editor of The Leaf Online. He has written over a hundred published articles for outlets including Cannabis Now, High Times, Hemp Magazine, Green Flower Media, the Wine Industry Network, ABV Magazine, and About.com. As a journalist and cannabis researcher, Mitchell has written on the medical effects of nearly two-dozen cannabinoids and terpenes, the environmental impacts of cultivation, the history of hemp, cannabis genetics, vaporizers, and cannabis doctors.

Mitchell is passionate about education. For half a decade, Mitchell worked at Harborside, the world’s largest medical cannabis dispensary, where he educated thousands of patients about cannabis medicine. As a regional director for 2010's Proposition 19 campaign he educated voters about the need to legalize adult-use cannabis and was part of a team that came 4% away from making California the first adult-use state. He is also a professor at Oaksterdam University where he teaches classes about hemp, dispensary operations, vape pens, and many other facets of the cannabis industry.

Mitchell is dedicated to creating a legal, regulated, and compliant cannabis industry focused on consumer safety. After spending a year as a senior consultant for the female-led compliance consultancy, Pistil + Stigma, Mitchell founded Full Spectrum Strategy, where he currently serves as the Head Lobbyist. Full Spectrum is currently working with Firefly Vapor to advocate for cannabis vape recycling and sustainability in the industry in both California and Colorado. In this role, Mitchell wrote and introduced an amendment to Colorado's Sunset Review Bill which will allow for the recycling of all “marijuana consumer waste” in Colorado.

One thought on “Endocannabinoid Profile: Anandamide”

Comments are closed.